🇺🇸 FDA
Patent

US 9573977

Method for preventing neoplastic transformation by inhibition of retinoblastoma protein inactivation

granted A61KA61K38/00A61K38/08

Quick answer

US patent 9573977 (Method for preventing neoplastic transformation by inhibition of retinoblastoma protein inactivation) held by The Regents of the University of California expires Mon Feb 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K38/00, A61K38/08, A61P, A61P35/00